Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Wide local excision, Interferon alfa-2a/2b, Acral melanoma, BRAF V600-mutant melanoma and the tag subtype-page.
Shares Wide local excision, BRAF V600-mutant melanoma, Advanced melanoma (unresectable stage III and stage IV), Nivolumab and the tag subtype-page.
Shares MEK1/2, Ipilimumab, RAS / RAF / MEK / ERK (MAPK), Nivolumab and the tag subtype-page.
Shares Wide local excision, Imatinib, IMRT / IGRT (modern external beam), Small-molecule kinase inhibitors and the tag subtype-page.
Shares MEK1/2, RAS / RAF / MEK / ERK (MAPK), IMRT / IGRT (modern external beam) and the tag subtype-page.
Shares CTLA-4, Ipilimumab, Nivolumab, PD-1 and the tag subtype-page.
Shares Ipilimumab, Nivolumab, IMRT / IGRT (modern external beam), Immune checkpoint inhibitors and the tag subtype-page.
Shares Nivolumab, PD-1, IMRT / IGRT (modern external beam), Pembrolizumab and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.